Health and Safety Executive Annual Report: Statistical Supplement 1992-93. London: HMSO, 1993.
2.
BraithwaiteRAGirlingAJ. Bovine reference materials for accuracy control of blood lead analysis. Fresenius Z Anal Chem1988; 332: 704–9.
3.
Water Pollution at Lowermoor North Cornwall. Report of the Lowermoor Incident Health Advisory Group. Truro: Cornwall and Isles of Scilly District Health Authority, 1989.
4.
Identification and control of pollutants of broad international significance. Document A/CONF. 48/8 prepared for the United Nations Conference on the Human Environment. Stockholm, 1972.
5.
World Health Organization. Environmental Health Criteria 3. Lead. Geneva: WHO, 1977.
6.
NordbergGF. Application of the ‘critical effect’ and ‘critical concentration’ to human risk assessment for cadmium. IARC Sci Publ1992; 118: 3–14.
7.
Control of Lead at Work. Approved Code of Practice. London: HMSO. 1985.
8.
Control of Lead at Work Regulations 1998. London: The Stationery Office Ltd, 1998.
9.
ClarksonTW. Molecular targets of metal toxicity. In: BrownSSSavoryJ, eds. Chemical Toxicology and Clinical Chemistry of Metals. London: Academic Press; 1983:217–26.
10.
ChisholmJJBarltropD. Recognition and management of children with increased lead absorption. Arch Dis Child1979; 54: 249–62.
11.
El-SharkawAMMorganWDCobboldSJaibMBEvansCJSomervaillcLJUnexpected mobilisation of lead during therapy. Lancet1986; ii: 249–50.
12.
SilbcrgeldEKSaukJSomermanMToddAMcNeillFFowlerBLead in bone; storage site, exposure source and target organ. Neurotoxicology1993; 142-3: 225-36.
13.
CoylePPhilcoxJCRofeAM. Clinical significance of metallothionein: a dealer in heavy metals. Clin Biochem Revs1993; 14: 118–25.
14.
SheltonKREglePMBigbeeJWKlannE. A nuclear matrix protein stabilised by lead exposure: current knowledge and future prospects. Neurotoxicology1993; 14: 61–8.
15.
MushakP. Mammalian biotransformation processes involving various toxic metalloids and metals. In: BrownSSSavoryJ, eds. Chemical Toxicology and Clinical Chemistry of Metals. London: Academic Press. 1983:227–45.
16.
GrazianoJHLeongJKFricdhcimE. 2,3-Dimercaptosuccinic acid: a new agent for the treatment of lead poisoning. J Pharmacol Exp Ther1978; 206: 696–700.
17.
GlotzcrDE. The current role of 2,3-dimercaptosuccinic acid (DMSA) in the management of childhood lead poisoning. Drug Safety1993; 9: 85–92.
18.
Rey-AlvarezSMenke-HargraveT. Dclcading dilemma: pitfalls in the management of childhood lead-poisoning. Paediatrics1987; 79: 214–17.
19.
ShiwenCYinYZhincngHXianguZZhaduYHuidongLCadmium exposure and health effects among residents in an irrigation area with ore dressing wastewater. Sci Total Environ1990; 90: 67–73.
20.
BuchetJPLauwerysRRoelsHBernardABruauxPClaeysFRenal effects of the cadmium burden of the general population. Lancet1990; 336: 699–702.
21.
HerberRFM. The World Health Organisation study on health effects of exposure to cadmium: morbidity studies. IARC Sci Publ1992; 118: 347–58.
22.
FribergLTPiscatorMNordbergGF. Occurrence, possible routes of exposure and daily intake. In: WeastRC, ed. Cadmium in the Environment. Cleveland: CRC Press; 1971.
23.
BucklerHMSmithWDFRccsWDW. Self poisoning with oral cadmium chloride. BMJ1986; 292: 1559–60.
24.
KjellstromT. Mechanism and epidemiology of bone effects cadmium. IARC Sci Publ1992; 118: 301–10.
25.
ChambersRCMcNaultyRJShockACampaJSNewman TaylorAJLaurentGJ. Cadmium selectively inhibits fibroblast procollagen production and proliferation. Am J Physiol1994; 267: L300–08.
26.
ToffolettoFApostoliPGhezziIBajACortonaGRizziITen year follow up of biological monitoring of cadmium-exposed workers. IARC Sci Puhl1992; 118: 107–11.
27.
RoelsHBernardAMCardenasABuchetJPLauwerysRHotterGMarkers of early renal changes induced by industrial chemicals. III. Application to workers exposed to cadmium. Br J Ind Med1993; 50: 37–48.
28.
LauwerysRRBernardAMRoelsHABuchetJP. Cadmium markers as predictors of nephrotoxic effects. Clin Chem1994; 40: 1391–4.
29.
BernardARoelsHBuchetJPCardenasALauwerysR. Cadmium and health: the Belgian experience. IARC. Sci Publ1992; 118: 15–33.
30.
DavisonAGNewman TaylorAJDarbishireJChettleDRGuthrieCJO'MalleyDCadmium fume inhalation and emphysema. Lancet1988; i: 663–7.
31.
CarruthersMMSmithB. Evidence of cadmium toxicity in a population living in a zinc-mining area. Pilot survey of Shipham residents. Lancet1979; i: 845–7.
32.
LemenRALeeJSWagonerJKBlejerHP. Cancer mortality among cadmium production workers. Ann NY Acad Sci1976; 271: 274–9.
33.
ArmstrongBGKazantzisG. The mortality of cadmium workers. Lancet1983; i: 1425–7.
34.
ThunMJSchnorrTMSmithABHalperinWELemenRA. Mortality among a cohort of US cadmium production workers — an update. J Natl Cancer Inst1985; 75: 325–33.
35.
KazantisGLamTHSullivanKR. Mortality of cadmium-exposed workers. A five-year update. Scand J Work Environ Health1988; 14: 220–3.
36.
KazantsisGBlanksRGSullivanKR. Is cadmium a human carcinogen?IARC. Sci Rep1992; 118: 435–46.
37.
BeeversDGCampbellBCGoldbergAMooreMRHawthorneVM. Blood cadmium in hypertensives and normotensives. Lancet1976; ii: 1222–4.
38.
StaessenRBernardABuchetJPClaeysFDekcmpcneerLDucoffreGEffects of cadmium exposure on the cardiovascular system and on calcium metabolism: results of a cross-sectional populations study. IARC Sci Publ1992; 118: 263–9.
39.
BraithwaiteRAArmstrongRFranklinDMChettleDRScottMC. Cadmium toxicokinetics following long term occupational exposure. In: AitioAAroAJarvisaloJVainoH, eds. Proceedings of the Joint International Symposium of the Nordic Trace Element Society and the International Union of Pure and Applied Chemistry: Trace Elements in dth and Disease. Espoo, Finland 5–8 June 19. Cambridge: Royal Society of Chemistry; 1991:95–103.
40.
SartorFRondiaDClaeysFBuchetJPDucoffreGLauwerysRFactors affecting the cadmium body burden in a population study. IARC Sci Publ1992; 118: 101–6.
41.
GompertzDChettleDRFletcherJGMasonHPerkinsJScottMCRenal dysfunction in cadmium smelters: relation to in-vivo liver and kidney cadmium concentrations. Lancet1983; i: 1185–7.
42.
RoclsHLauwerysRBuchetJPBernardAChettleDRAl-HaddadIK. In vivo measurement of liver and kidney cadmium in workers exposed to this metal. Environ Res1981; 26: 217–40.
43.
DonaldsonMDChambersRTWoolridgeMWWhicherJT. Stability of alpha-1-microglobulin, beta-2-microglobulin and retinol binding protein in urine. Clin Chim Acta1989; 179: 73–8.
44.
SchallerKHAngererJH. Biological monitoring in the occupational setting — relation to cadmium exposure. IARC Sci Rep1992; 118: 53–64.
45.
JungKPergandeMGraubaumHJFelsLMEndlUStolteH. Urinary proteins and enzymes as early indicators of renal dysfunction in chronic exposure to cadmium. Clin Chem1993; 39: 757–65.
46.
MuellerPW. Detecting the effects of cadmium toxicity [editorial; comment]. Clin Chem1993; 39: 743–5.
47.
BernardARoelsHThielemansNVan-LierdeMLauwerysR. Assessment of the causality of the cadmium protein relationships in the urine of the general population with reference to the Cadmibel study. IARC Sci Publ1992; 118: 341–6.
48.
Health and Safety Executive. Cadmium: Health and Safety Precaution: Guidance Note EH 1. London: HMSO, 1986.
49.
EyblVKotyzovaDKoutenskyJJonesMMSinghPK. Effect of chelators, monoisoamyl meso-2,3-dimercaptosuccinate and N-(4-methylbenzyl)-4-O-(beta-D-galactopyranosyl)-D-glucamine-N-carbodithioate on cadmium and essential element levels in mice. Analyst1995; 120: 855–7.
50.
MajorRH. Some landmarks in the history of lead poisoning. Ann Med Hist1931; 3: 218–27.
51.
FranklinB. The pernicious effects of lead. In: FranklinB, ed. The Works of Ben Franklin. Philadelphia: BC Buzby; 1818.
52.
GrandjeanP. International perspectives of lead exposure and lead toxicity. Neurotoxicology1993; 14: 7–14.
53.
FellGS. Lead toxicity: problems of definition and laboratory evaluation. Ann Clin Biochem1984; 21: 453–60.
54.
GoyerRA. Lead toxicity: current concerns. Env-Health Perspect1993; 100: 177–87.
55.
CoylePHaywoodMRRofeAM. Living with lead. An Australian overview. Clin Biochem Revs1994; 15: 179–87.
56.
MatteTDProopsDPalazuelosEGraefJAvilaHA. Acute high-dose lead exposure from beverage contaminated by traditional Mexican pottery. Lancet1994; 344: 1064–5.
57.
BaylyGRBraithwaiteRASheehanTMTDyerNHGrimleyCFernerRE. Lead poisoning from Asian traditional remedies in the West Midlands — report of a series of five cases. Hum Experiment Toxicol1995; 14: 24–8.
58.
NeedlemanHLGunnoeCLevitonAReedRPeresieHMaherCDeficits in psychological and classroom performance in children with elevated dentine lead levels. N Engl J Med1979; 300: 689–95.
59.
NeedlemanHLSchellABellingerD. The long-term effects of exposure to low doses of lead in children: an 11 year follow up report. N Engl J Med1990; 322: 83–8.
60.
DelvesHTClaytonBECarmichaelA. An appraisal of the analytical significance of tooth lead measurements as possible indices of environmental exposure of children to lead. Ann Clin Biochem1982; 19: 329–37.
61.
HatzakisAKokkeviAMaraveliasCKatsouyanniKSalaminiosFKalandidiAPsychomotor intelligence deficits in lead-exposed children. In: SmithMAGreenLDSorsA, eds. Lead Exposure and Child Development. London: Kluwcr; 1989:211–23.
62.
BaghurstPAMcMichaelAJWiggNRVimpaniGVRobertsonEFRobertsRJEnvironmental exposure to lead and children's intelligence at the age of seven years; the Port Pirie cohort study. N Engl J Med1992; 327: 1279–84.
63.
HarveyPGHamlinMWKumarRMorganGSpurgeonADelvesHT. Relationship between blood lead, behaviour, psychometric and neuropsychological test performance in young children. Brit J Dev Psychol1988; 6: 145–56.
64.
FultonMRaabGThomsonGLaxenDHunterRHepburnW. Influence of blood lead on the ability and attainment of children in Edinburgh. Lancet1987; i: 1221–6.
65.
PocockSJSmithM.BaghurstP.Environmental lead and children's intelligence: a systematic review of the epidemiological evidence. BMJ1994; 309: 1189–97.
66.
PalcaJ. Lead researcher confronts accusers in public hearing. Science1992; 256: 437–8.
67.
CDC Strategic Plan for the Elimination of Childhood Lead Poisoning. Atlanta: Centers for Disease Control Departments of Health and Human Services, 1991.
68.
DiermeyerMHedbergKFlemingD. Backing off universal childhood lead screening in the USA: opportunity or pitfall? [commentary]. Lancet1994; 344: 1587–8.
69.
Department of the Environment. European Community Screening Programme for Lead: United Kingdom Results for 1981. Pollution Report No 18. London: HMSO, 1984.
70.
Department of the Environment. UK Blood Lead Monitoring Programme 1984-1987: Results for 1987. Pollution Report No 28. London: HMSO. 1990.
71.
Environmental Data Services Ltd, London. ENDS Report1997 (269, June).
72.
MillborneERussellJ. Britain must replace its lead pipes to meet WHO standards for drinking water [letter]. BMJ1995; 310: 1408–9.
73.
ChurchHJDayPBraithwaiteRABrownSS. Binding of lead to a metallothionein-like protein in human erythrocytes. J Inorg Biochem1993; 49: 55–68.
74.
BarltropDSmithAM. Kinetics of lead interactions with human erythrocytes. Postgrad Med J1985; 51: 770–3.
75.
RossiECostinKAGarcia-WebbP. Effect of occupational lead exposure on lymphocyte enzymes involved in haem biosynthesis. Clin Chem1990; 36: 1980–3.
76.
LabbeRF. Lead poisoning mechanisms [editorial]. Clin Chem1990; 36: 1870–1.
77.
PagliucaABaldwinDLestasANWallisRMBellinghamAJMuftiGJ. Lead poisoning: clinical biochemical and haematological aspects of a recent outbreak. J Clin Pathol1990; 43: 277–81.
78.
LeeWR. What happens in lead poisoning?J Roy Coll Phys1981; 15: 48–54.
79.
CardenasARoelsHBernardAMBarbonRBuchetJPLauwerysRRMarkers of early renal changes induced by industrial pollutants. II Application to workers exposed to lead. Br J Ind Med1993; 50: 28–36.
80.
ChisholmJJJr. Lead poisoning. Sci Am1971; 224: 15–23.
81.
GrahamJAMaxtonDGTwortCH. Painter's palsy: a difficult case of lead poisoning. Lancet1981; ii: 1159–61.
82.
ChisholmJJJr. Mobilisation of lead by calcium disodium edetate: a reappraisal. Am J Dis Child1987; 141: 1256–7.
83.
BergerOGGreggDJSuccopPA. Using unstimulated urinary lead excretion to assess the need for chelation in the treatment of lead poisoning. J Paediatr1990; 116: 46–51.
84.
PiomelliSRosenJFChisholmJJGraefJW. Management of childhood lead poisoning. Paediatrics1984; 105: 523–32.
85.
BraithwaiteRASheehanTMDaviesRC. Blood lead analysis: beware of contaminated collection tubes. Association of Clinical Biochemists News Sheet1991 (344, December): 26–7.
86.
CrickJFlegalAR. Contaminant lead in blood-collection tubes for trace element studies. Clin Chem1991; 38: 600–1.
87.
TaylorA. The use of internal quality control materials for the preparation and maintenance of reliable methods for the measurement of lead in blood. Fresenius Z Anal Chem1988; 332: 732–5.
88.
BullockDGSmithNJWhiteheadTP. External quality assessment of assays of lead in blood. Clin Chem1986; 32: 1884–9.
89.
DelvesHT. Analytical techniques for blood lead measurement. J Anal Toxicol1977; 1: 262–4.
90.
TaylorAMajumdarGDelvesHT. Probable self-administration of lead [letter]. Lancet1985; i: 513.
91.
TaylorA. Usefulness of measurements of trace elements in hair. Ann Clin Biochem1986; 23: 364–78.
92.
CampbellMJDelvesHT. Accurate and precise determination of lead isotope ratios in clinical and environmental samples using inductively coupled plasma source mass spectrometry. J Anal Atom Spectrom1989; 4: 235–6.
93.
KeenRWDeaconACDelvesHTMoretonJAFrostPG. Indian herbal remedies for diabetes as a cause of lead poisoning. Postgrad Med J1994; 70: 113–4.
94.
PiomelliSBernardDGuineeVFYoungPGayG. The FEP free erythrocyte porphyrin test: a simple sensitive screening test for lead poisoning. Clin Chem1972; 50: 254–9.
95.
ZwennisWCMFranssenACWijnansM. Use of zinc protoporphyrin in screening individuals for exposure to lead. Clin Chem1990; 36: 1456–9.
96.
ParsonsPJReillyAAHussainA. Observational study of erythrocyte protoporphyrin screening test for detecting low lead exposure in children: impact of lowering the blood lead action threshold. Clin Chem1991; 37: 216–25.
97.
HurstPLHughesPM. Poor correlation between erythrocytic 5-aminolaevulinic acid dehydratase activity and blood lead concentration [letter]. Clin Chem1985; 31: 1244–5.
98.
HoldenA. St Albans Poisoner: Life and Crimes of Graham Young. London: Black Swan (Trans-world), 1995.
99.
ReedMDCrawleyJFaroSNPieperSJKurlandLT. Thallotoxicosis: acute manifestations and sequelae. JAMA1963; 183: 516–22.
100.
InsleyBMGruffermanSAyliffeA. Thallium poisoning in cocaine abusers. Am J Emerg Med1986; 4: 545–8.
101.
DolgnerRBrockhausAEwersUWiegandHMajewskiFSoddemannH. Repeated surveillance of exposure to thallium in a population living in the vicinity of a cement plant emitting dust containing thallium. Int Arch Occup Environ Health1983; 52: 79–84.
102.
MooreDHouseIDixonA. Thallium poisoning. Diagnosis may be elusive but alopecia is the clue. BMJ1993; 306: 1527–9.
103.
ChandlerHAArchboldGPRGibsonJMO'CallaghanPMarksJNPethybridgeRJ. Excretion of a toxic dose of thallium. Clin Chem1993; 36: 1506–9.
104.
CavanaghJB. What have we learned from Graham Frederick Young? Reflections on the mechanisms of thallium neurotoxicity. Neuropathol Appl Neurobiol1991; 17: 3–9.
105.
Martin-GilJDelibes de CastroGZapatero-MagdalenoPSarabia-HerreroFJ. Preserving the ancients with vermilion [letter]. Lancet1994; 344: 1776.
106.
O'SheaJG. The death of Paganini. J Roy Coll Phys1988; 22: 104.
YehTPildesRSFirorHVSzantoPB. Mercury poisoning from mercurochrome therapy of infected omphalocoele [letter]. Lancet1978; i: 210.
109.
LaundyTAdamAEKershawJBRainfordDJ. Deaths after peritoneal lavage with mercuric chloride solutions: case report and review of the literature. BMJ1984; 289: 96–8.
110.
PetersonDEKanarekMSKuykendallMADiedrichJMAndersonHARemingtonPLFish consumption patterns and blood mercury levels in Wisconsin Chippewa Indians. Arch Environ Health1994; 49: 53–8.
111.
SvenssonBGNilssonAJonssonESchutzAAkessonBHagmarL. Fish consumption and exposure to persistent organochlorine compounds, mercury, selenium and methylamines among Swedish fisherman. Scand J Work Environ Health1995; 21: 96–105.
112.
HaradaM. Minnamata disease: methyl mercury poisoning in Japan caused by environmental pollution. Crit Rev Toxicol1995; 25: 1–24.
113.
PalhetaDTaylorA. Mercury in environmental and biological samples from a gold mine in the Amazon region of Brazil. Sci Total Environ1995; 168: 63–9.
114.
MantTGLewisJLMattooTKRigdenSPVolansGNHouseIMMercury poisoning after disc battery ingestion. Hum Toxicol1987; 6: 179–81.
115.
KewJMorrisCAihieAFyshRJonesSBrooksD. Arsenic and mercury intoxication due to Indian ethnic remedies. BMJ1993; 306: 506–7.
116.
SheerinNSMonkPNAslamMThurstonH. Simultaneous exposure to lead, arsenic and mercury from Indian ethnic remedies. Br J Clin Pract1994; 48: 332–3.
117.
LauwerysRBonnierCEvrardPGennartJPBernardA. Prenatal and early postnatal intoxication by inorganic mercury resulting from the maternal use of mercury containing soap. Hum Toxicol1987; 6: 253–6.
118.
MucklowES. Health hazard from mercury soaps. Lancet1989; i: 448.
119.
TunnessenWWJrMcMahonKJBaserM. Acrodynia: exposure to mercury from fluorescent light bulbs. Paediatrics1987; 79: 786–7.
FribergL. Inorganic Mercury. International Programme on Chemical Safety, Environmental Health Criteria 118. Geneva: World Health Organisation, 1991.
122.
FowlerBA. Mechanisms of kidney cell injury from metals. Environ Health Perspect1992; 100: 57–63.
123.
ClarksonTW. Mercury: major issues in environmental health. Environ Health Perspect1992; 100: 31–8.
124.
PendergrassJCHaleyBEVimyMJWinficldSALorscheiderFL. Mercury vapor inhalation inhibits binding of GTP to tubulin in rat brain: similarity to a molecular lesion in Alzheimer diseased brain. Neurotoxicology1997; 18: 315–24.
125.
Gala-GorchevH. Dietary intake, levels in food and estimated intake of lead, cadmium and mercury. Food Addit Contam1993; 10: 115–28.
126.
WeinerJANylanderM. An estimation of the uptake of mercury from amalgam fillings based on urinary excretion of mercury in Swedish subjects. Sci Total Environ1995; 168: 255–65.
127.
BarregardLSallstenGJarvholmB. People with high mercury uptake from their own dental amalgam fillings. Occup Environ Med1995; 52: 124–8.
128.
HalbachS. Combined estimation of mercury species released from amalgam. J Dent Res1995; 74: 1103–9.
129.
ClausenJ. Mercury and multiple sclerosis. Acta Neurol Scand1993; 87: 461–4.
FungYKMeadeAGRackEPBlotckyAJClaassenJPBeattyMWDetermination of blood mercury concentrations in Alzheimer's patients. J Toxicol Clin Toxicol1995; 33: 243–7.
132.
EleyBM. The future of dental amalgam: a review of the literature. Part 6: possible harmful effects of mercury from dental amalgam. Br Dent J1997; 182: 455–9.
133.
HenrikssonEMattssonUHakanssonJ. Healing of lichenoid reactions following removal of amalgam. A clinical follow-up. J Clin Periodontol1995; 22: 287–94.
HandleyJToddJ.BurrowsD.Mercury allergy in a contact dermatitis clinic in Northern Ireland. Contact Dermatitis1993; 29: 258–61.
136.
EcheverriaDHeyerNJMartinMDNalewayCAWoodsJSBittnerAC. Behavioural effects of low-level exposure to elemental mercury among dentists. Neurotoxicol Teratol1995; 17: 161–8.
137.
GallagherJDNoellcRJMcCannFV. Mercury suppression of a potassium current in human B lymphocytes. Cell Signal1995; 7: 31–8.
138.
GoodwinCAWheeler-JonesCPNamiranianSBokkalaSKakkarVVAuthiKSIncreased expression of procoagulant activity on the surface of human platelets exposed to heavy metal compounds. Biochem J1995; 308: 15–21.
139.
FranchiELoprienoGBallardinMPetrozziLMiglioreL. Cytogenetic monitoring of fishermen with environmental mercury exposure. Mutat Res1994; 320: 23–9.
140.
JanssonGHarms-RinghdahlM. Stimulating effects of mercuric and silver ions on the superoxide anion production in human polymorphonuclear lymphocytes. Free Radic Res Commun1993; 18: 87–98.
141.
HerrstromPHolmenAKarlssonARaihleGSchutzAHogstedtB. Immune factors, dental amalgam and low dose exposure to mercury in Swedish adolescents. Arch Environ Health1994; 49: 160–4.
142.
LevinMJacobsJPolosPG. Acute mercury poisoning and mercurial pneumonitis from gold ore purification. Chest1988; 94: 554–6.
143.
WaldronHA. Did the Mad Hatter have mercury poisoning?BMJ1983; 287: 1961.
144.
BuxtonJTHewittJCGadsdenRBradhamGB. Metallic mercury embolism. Report of cases. JAMA1965; 193: 573–5.
CampbellJRClarksonTWOmarMD. The therapeutic use of 2,3-dimercaptopropane-1-sulphonate in two cases of mercury poisoning. JAMA1986; 256: 3217–30.
151.
ToetAEvan DijkASavclkoulTJMeulcnbeltJ. Mcrcury kinetics in a case of severe mercuric chloride poisoning treated with dimercapto-1-propane sulphonate. Hum Exp Toxicol1994; 13: 11–6.
152.
ShibataAOhneseitPFTsaiYCSpruckCHNicholsPWChiangHSMutational spcctrum in the p53 gene in bladder tumours from the endemic area of blackfoot disease in Taiwan. Carcinogenesis1994; 15: 1085–7.
153.
ChatterjeeADasDMandalBKChowdhuryTRSamantaGChakrabortiD. Arsenic in ground water in six districts of West Bengal, India: the biggest arsenic calamity in the World. Part 1. Arsenic species in drinking water and urine of affected people. Analyst1995; 120: 643–50.
154.
DasDChatterjeeAMandalBKSamantaGChakrabortiDChandaB. Arsenic in ground water in six districts of West Bengal, India: the biggest arsenic calamity in the World. Part 2. Arscnic concentration in drinking water, hair, nails, urine, skin-scale and liver tissue (biopsy) of the affected people. Analyst1995; 120: 917–24.
155.
StocpplerMVahterM. Arsenic. In: HerberRFMStocpplerM, eds. Truce Element Analysis in Biological Specimens. Amsterdam: Elsevier; 1994:291–320.
156.
WilkinsonSPMcHughPHorsleySTubbsHLewisMThouldAArsine toxicity aboard the Asiafreighter. BMJ1975; 3: 559–63.
157.
ClarksonTW. Molecular targets of metal toxicity. In: BrownSSSavoryJ, eds. Chemical Toxicology and Clinical Chemistry of Metals. London: Academic Press; 1983:211–26.
158.
LafontaineA. Health effects of arsenic. In: Di FerranteE, ed. CEC Trace Metals: Exposure and Health Effects. Oxford: Pergamon Press; 1978:107–16.
159.
HeavenRDuncanMVukeljaSJ. Arsenic intoxication presenting with macrocytosis and peripheral neuropathy, without anaemia. Acta Haematol1994; 92: 142–3.
160.
ChenCJKuoTLWuMM. Arsenic and cancers [letter]. Lancet1988; i: 414–5.
161.
LeXCCullenWRReimerKJ. Human urinary arsenic excretion after one-time ingestion of seaweed, crab and shrimp. Clin Chem1994; 40: 617–24.
162.
VahterM. What are the chemical forms of arsenic in urine and what can they tell us about exposure?Clin Chem1994; 40: 679–80.
163.
KoonsRDPetersCA. Axial distribution of arsenic in individual human hairs by solid sampling graphite furnace AAS. J Anal Toxicol1994; 18: 36–40.
164.
MooreDFO'CallaghanCABerlyneGOggCSDaviesHAHouseIMAcute arsenic poisoning: absence of polyneuropathy after treatment with 2,3-dimercaptopropanesulphonate (DMPS). J Neurol Neurosurg Psychiatry1994; 57: 1133–5.
165.
RichardsonBA. Sudden infant death syndrome: a possible primary cause. J Forensic Sci Soc1994; 34: 199–204.
166.
FlemingPJCookeMChantlerSMGoldingJ. Fire retardants, biocides, plasticisers and sudden infant deaths [editorial]. BMJ1994; 309: 1594–6.
167.
RichardsonBA. Cot mattresses and sudden infant death syndrome [letter]. Lancet1995; 345: 1045.
168.
HowatsonAGPatrickWJAFellGSLyonTDBGibsonAAM. Cot mattresses and sudden infant death syndrome [letter]. Lancet1995; 345: 1044–5.
169.
De-WolffFA. Antimony and health [editorial]. BMJ1995; 310: 1216–7.
170.
WarnockDWDelvesHTCampbellCKCroudaceIWDaveyKGJohnsonMToxic gas generation from plastic mattresses and sudden infant death syndrome. Lancet1995; 346: 1516–20.
171.
DezateuxCDelvesHTStocksJWadeAPilgrimLCostelocK. Urinary antimony in infancy. Arch Dis Child1997; 76: 432–6.
172.
WhiteGPMathiasCGDavinJS. Dermatitis in workers exposed to antimony in a smelting process. J Occup Med1993; 35: 392–5.
173.
ThomasDWSobeckiSHartleyTFCoylePAlpMH. Variable absorption and excretion of bismuth and its potential for toxicity. In: BrownSSSavoryJ, eds. Chemical Toxicology and Clinical Chemistry of Metals. London: Academic Press; 1983:391–4.
174.
PlayfordRJMatthewsCHCampbellMJDelvesHTHlaKKHodgsonHJBismuth induced encephalopathy caused by tripotassium dicitratobismuthate in a patient with chronic renal failure. Gut1990; 31: 359–60.
175.
KubullaJWilkenRDJantzenEKwanKKChauYK. Speciation and genotoxicity of butyltin compounds. Analyst1995; 120: 667–73.
176.
WalkerAW, ed. Clinical and Analytical Hand-book, 3rd edition. Guildford, UK: SAAS Trace Element Laboratories, 1998.
177.
SchramelPWendlerIAngererJ. The determination of metals (antimony, bismuth, lead, cadmium, mercury, palladium, platinum, tellurium, thallium, tin and tungsten) in urine samples by inductively coupled plasma-mass spectrometry. Int Arch Occup Health1997; 69: 219–23.
178.
McElvaineMDHarderEMJohnsonLBaerRDSatzgerRD. Lead poisoning from the use of Indian folk medicines. JAMA1990; 264: 2212–3.
179.
Sanchez-GuerreroJColditzGAKarlsonEWHunterDJSpeizerFELiangMH. Silicone breast implants and the risk of connective-tissue diseases and symptoms. N Engl J Med1995; 332: 1666–70.